Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial
Titel:
Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial
Auteur:
Froesch, Patrizia Mark, Michael Rothschild, Sacha I. Li, Qiyu Godar, Gilles Rusterholz, Corinne Oppliger Leibundgut, Elisabeth Schmid, Sabine Colombo, Ilaria Metaxas, Yannis König, David Sessa, Cristiana Gautschi, Oliver Früh, Martin